1. Home
  2. REPL vs SBH Comparison

REPL vs SBH Comparison

Compare REPL & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
    SELLHOLDBUYas of 20 hours ago
  • SBH
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • REPL 2015
  • SBH 1964
  • Country
  • REPL United States
  • SBH United States
  • Employees
  • REPL N/A
  • SBH N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • SBH Other Specialty Stores
  • Sector
  • REPL Health Care
  • SBH Consumer Discretionary
  • Exchange
  • REPL Nasdaq
  • SBH Nasdaq
  • Market Cap
  • REPL 851.0M
  • SBH 940.7M
  • IPO Year
  • REPL 2018
  • SBH 2006
  • Fundamental
  • Price
  • REPL $8.40
  • SBH $8.94
  • Analyst Decision
  • REPL Strong Buy
  • SBH Buy
  • Analyst Count
  • REPL 6
  • SBH 6
  • Target Price
  • REPL $20.00
  • SBH $12.70
  • AVG Volume (30 Days)
  • REPL 717.2K
  • SBH 2.3M
  • Earning Date
  • REPL 05-15-2025
  • SBH 05-08-2025
  • Dividend Yield
  • REPL N/A
  • SBH N/A
  • EPS Growth
  • REPL N/A
  • SBH 4.93
  • EPS
  • REPL N/A
  • SBH 1.66
  • Revenue
  • REPL N/A
  • SBH $3,723,624,000.00
  • Revenue This Year
  • REPL $31.16
  • SBH $0.99
  • Revenue Next Year
  • REPL N/A
  • SBH $1.52
  • P/E Ratio
  • REPL N/A
  • SBH $5.45
  • Revenue Growth
  • REPL N/A
  • SBH 0.57
  • 52 Week Low
  • REPL $4.92
  • SBH $8.25
  • 52 Week High
  • REPL $17.00
  • SBH $14.79
  • Technical
  • Relative Strength Index (RSI)
  • REPL 21.08
  • SBH 46.89
  • Support Level
  • REPL $10.17
  • SBH $8.66
  • Resistance Level
  • REPL $10.78
  • SBH $9.22
  • Average True Range (ATR)
  • REPL 0.65
  • SBH 0.36
  • MACD
  • REPL -0.21
  • SBH 0.06
  • Stochastic Oscillator
  • REPL 0.93
  • SBH 65.87

Stock Price Comparison Chart: REPL vs SBH

REPL
SBH
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0510152025303540REPL VS SBH

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)

Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use